Cysteine protease inhibitors are a class of small molecules that directly target and inhibit cysteine proteases, a group of enzymes that include cathepsins. These inhibitors can indirectly affect cystatin B by reducing the need for its inhibitory function, as cystatin B primarily acts to regulate cysteine protease activity. Cystatin B inhibitors represent a class of compounds that specifically target and modulate the activity of cystatin B, a naturally occurring cysteine protease inhibitor found in various tissues. Cystatin B is a member of the cystatin superfamily, and it plays a vital role in regulating the activity of cysteine proteases, particularly cathepsins. The inhibition of cystatin B is of interest in scientific research to better understand its functions and the broader proteolytic processes it influences.
These cysteine protease inhibitors can be valuable tools for studying the functions of cysteine proteases and their regulation by cystatin B. Their use in experimental settings can help researchers better understand the complex interplay between proteases and protease inhibitors in various biological processes. Researchers studying cystatin B inhibitors aim to elucidate the specific mechanisms by which they affect cystatin B's inhibitory function. By investigating these interactions, scientists can gain a deeper understanding of the roles of cystatin B and its potential implications for cellular homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
Leupeptin is another irreversible cysteine protease inhibitor that can directly block the activity of cathepsins and other cysteine proteases. Similar to E64, leupeptin's action may lessen the requirement for cystatin B inhibition. | ||||||
CA-074 | 134448-10-5 | sc-202513 | 1 mg | $321.00 | ||
These compounds are selective inhibitors of cathepsin B. By specifically targeting cathepsin B activity, they can indirectly affect the need for cystatin B inhibition of this particular cysteine protease. | ||||||
Z-FA-FMK | 197855-65-5 | sc-201303 sc-201303A | 1 mg 5 mg | $128.00 $372.00 | 19 | |
This compound is a broad-spectrum cysteine protease inhibitor that can inhibit multiple cathepsins. Its use can lead to reduced activity of cathepsins, potentially reducing the reliance on cystatin B for inhibition. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
Aloxistatin is a selective inhibitor of cathepsin B. By inhibiting this specific cathepsin, it can reduce the need for cystatin B to control cathepsin B activity. | ||||||